The majority of all prescriptions dispensed within the benefit were for Ozempic (54.7%), and the majority outside the benefit was for Saxenda (87.8%)
Used as part of a clinically supervised weight-management plan
Duration of treatment is based on each individual's goal, starting weight, underlying health, age, gender, response to treatment, and other factors
Three-dimensional reconstructions of mouse circumvallate taste buds using serial blockface scanning electron microscopy: I
Updated guidelines support referrals for evaluation for patients and clients who meet established criteria, such as higher BMI and/or weight-related conditions, especially when non-surgical approaches havent produced adequate or lasting results
Produced by Swanson, a trusted supplement brand established in 1969